Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 4957-4969

  Chen, Feng ^a   Zhang, Xiao Hong ^a   Hu, Xiao Dan ^a   Zhang, Wei ^a   Lou, Zhi Chao ^a   Xie, Li Hua ^a   Liu, Pei Dang ^b   Zhang, Hai Qian ^a,b  

^a NANJING UNIVERSITY OF AERONAUTICS AND ASTRONAUTICS   (China)

^b Southeast University   (China)

Author keywords

Breast cancer cells; Ceria nanoparticles; Neogambogic acid; Radiosensitization; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CERIA NANOPARTICLE; CERIUM OXIDE; NANOMATERIAL; NANOPARTICLE; NEOGAMBOGIC ACID; RADIOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AMINE; CERIUM; METAL NANOPARTICLE; NEO-GAMBOGIC ACID; XANTHENE DERIVATIVE;

ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MCF 7 CELL LINE; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; TISSUE INJURY; APOPTOSIS; BREAST TUMOR; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CHEMISTRY; DRUG EFFECTS; FEMALE; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; RADIATION RESPONSE;

AMINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CERIUM; FEMALE; G2 PHASE; HUMANS; MCF-7 CELLS; METAL NANOPARTICLES; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; XANTHENES;

EID: 84939616894     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S82980     Document Type: Article

References (59)

1. Montazerabadi AR, Sazgarnia A, Bahreyni-Toosi MH, Ahmadi A, Aledavood A. The effects of combined treatment with ionizing radiation and indocyanine green-mediated photodynamic therapy on breast cancer cells. J Photochem Photobiol B Biol. 2012;109:42-49.
2. Xie Q, Zhou Y, Lan G, et al. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways. Biochem Biophys Res Commun. 2014;449(1):88-93.
3. Kawasaki ES, Player A. Nanotechnology, nanomedicine, and the development of a new, effective therapies for cancer. Nanomedicine. 2005; 1(2):101-109.
4. Shen J, Song G, An M, et al. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy. Biomaterials. 2014;35(1):316-326.
5. Eom HJ, Choi J. Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett. 2009;187(2):77-83.
6. Xu C, Qu XG. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological application. NPG Asia Mater. 2014;6:e90.
7. Hussain S, Al-Nsour F, Rice AB, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012;6(7):5809-5820.
8. Ciofani G, Genchi GG, Liakos I, et al. Effect of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion. Pharm Res. 2013;30(8):2133-2145.
9. Rocca A, Mattoli V, Mazzolai B, Ciofani G. Cerium oxide nanoparticles inhibit adipogenesis in rat mesenchymal stem cells: potential therapeutic implication. Pharm Res. 2014;31(11):2952-2962.
10. Walker C, Das S, Seal S, et al. Catalytic properties and biomedical applications of cerium oxide nanoparticles. Environ Sci Nano. 2015;2(1):33-53.
11. Colon J, Hsieh N, Ferguson A, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010;6(5):698-705.
12. Tarnuzzer RW, Colon J, Patil S, Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005;5(12):2573-2577.
13. Chaachouay H, Ohneseit P, Toulany M, Kehlbach R, Multhoff G, Rodemann HP. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol. 2011;99(3):287-292.
14. Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010; 330(6009):1344-1348.
15. Yuk JM, Shin DM, Song KS, et al. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy. Autophagy. 2010;6(1):46-60.
16. Kim R, Emi M, Tanabe K, et al. The role of apoptosis or nonapoptosis cell death in determining cellular response to anticancer treatment. EJSO. 2006;32(3):369-377.
17. Mei W, Dong C, Hui C, et al. Gambogenic acid kills lung cancer cells through aberrant autophagy. PLoS One. 2014;9(1):e83604.
18. Zhou GZ, Zhang SN, Zhang L, Sun GC, Chen XB. A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells. Pharm Biol. 2014;52(1):111-116.
19. Yan F, Wang M, Chen H, et al. Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cell. Eur J Pharmacol. 2011;652(1-3):23-32.
20. Yu XJ, Han QB, Wen ZS, Ma L, Gao J, Zhou GB. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells. Cancer Lett. 2012;322(2):185-194.
21. Zhou J, Luo YH, Wang JR. Gambogenic acid induction of apoptosis in a breast cancer cell line. Asian Pac J Cancer Prev. 2013;14(12): 7601-7605.
22. Patil S, Kuiry SC, Seal S, Vanfleet R. Synthesis of nanocrystalline ceria particles for high temperature oxidation resistant coating. J Nanopart Res. 2002;4(5):433-438.
23. Zhou XD, Huebner W, Anderson HU. Room-temperature homogeneous nucleation synthesis and thermal stability of nanometer single crystal CeO2. Appl Phys Lett. 2002;80(20):3814-3816.
24. Bumajdad A, Zaki MI, Eastoe J, Pasupulety L. Microemulsion-based synthesis of CeO2 powders with surface area and high-temperature stabilities. Langmuir. 2004;20(25):11223-11233.
25. Xue Y, Luan QF, Yang D, Yao X, Zhou KB. Direct evidence for hydroxyl radical scavenging activity of cerium oxide nanoparticles. J Phys Chem C. 2011;115(11):4433-4438.
26. Barbara DA, Santucci S, Benedetti E, Di Loreto S, Phani AR, Falone S. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr Nanosci. 2009;5(2):167-176.
27. Cimini A, D’Angelo B, Das S, et al. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of A beta aggregates modulate neuronal survival pathways. Acta Biomater. 2012;8(6): 2056-2067.
28. Santos MJ, Quintanilla RA, Toro A, et al. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem. 2005; 280(49):41057-41068.
29. Patil S, Reshetnikov S, Haldar MK, et al. Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: a potential drug delivery device. J Phys Chem. 2007;111(24):8437-8442.
30. Sazgarnia A, Montazerabadi AR, Bahreyni-Toosi MH, Ahmadi A, Aledavood A. In vitro survival of MCF-7 breast cancer cells following combined treatment with ionizing radiation and mitoxantrone-mediated photodynamic therapy. Photodiagnosis Photodyn Ther. 2013;10(1):72-78.
31. Cui FB, Li RT, Liu Q, et al. Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer. Cancer Lett. 2014;346(1):53-62.
32. Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials. 2012;33(27):6408-6419.
33. Roa W, Zhang X, Guo L, et al. Gold nanoparticles sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 2009;20(37):375101.
34. Klionsky DJ, Abeliovich H, Agostinis P, et al. Guidelines for use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4(2):151-175.
35. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313-326.
36. Kim S, Choi JE, Choi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro. 2009; 23(6):1076-1084.
37. Harhaji L, Isakovic A, Raicevic N, et al. Multiple mechanisms underlying the anticancer action of nanocrystalline. J Appl Polymer Sci. 2007;568(1-3):89-98.
38. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005; 5(9):726-734.
39. Whiter E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009;15(17):5308-5316.
40. Amaravadi RK, Lippincott-Schwartz J, Yin XM, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011;17(4):654-666.
41. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as a novel therapeutic strategies in cancer. Autophagy. 2010;6(3):322-329.
42. Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10(9): 1533-1541.
43. Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45(6):487-498.
44. White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010;22(2):212-217.
45. Milani M, Rzymski T, Mellor HR, et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 2009;69(10):4415-4423.
46. Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther. 2011;11(2):157-168.
47. Kim RH, Coates JM, Bowles TL, et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009;69(2):700-708.
48. Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010;70(9):3431-3434.
49. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306(5698):990-995.
50. Zhang Y, Yu C, Huang G, Wang C, Wen L. Nano rare-earth oxides induced size-dependent vacuolization: an independent pathway from autophagy. Int J Nanomedicine. 2010;5:601-609.
51. Gao Z, Sarsour EH, Kalen AL, Li L, Kumar MG, Goswami PC. Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells. Nanomed Nanotechnol Biol Med. 2013;9(4):558-569.
52. Shi JM, Bai LL, Zhang DM, et al. Saxifragifolin D induces the interplay between apoptosis and autophagy in breast cancer cells through ROD-dependent endoplasmic reticulum stress. Biochem Pharmacol. 2013;85(7):913-926.
53. Azad MB, Chen YQ, Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implication for cancer progression and treatment. Antioxid Redox Signal. 2009;11(4):777-790.
54. Sahu T, Bisht SM, Das RK, Kirit R. Nanoceria: synthesis and biomedical applications. Curr Nanosci. 2013;9(5):588-593.
55. Briggs A, Corde S, Oktaria S, et al. Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation. Nanomedicine. 2013;9(7):1098-1105.
56. Beche E, Charvin P, Perarnau D, et al. Ce 3d XPS investigation of cerium oxides and mixed cerium (CexTiyOz). Surf Interface Anal. 2008; 40(3-4):264-267.
57. Escamilla-Perea L, Nava R, Pawelec B, et al. SBA-15-supported gold nanoparticles decorated by CeO2: structural characteristics and CO oxidation activity. Appl Catal A. 2010;381(1-2):42-53.
58. Tuller HL, Nowick AS. Defect structure and electrical properties of nonstoichiometric CeO2 single crystals. J Electrochem Soc. 1979; 126(2):209-217.
59. Boronin AI, Slavinskaya EM, Danilova IG, et al. Investigation of palladium interaction with cerium oxide and its state in catalysts for low-temperature CO oxidation. Catal Today. 2009;144(3-4):201-211.